跳至主要内容
临床试验/CTRI/2024/09/074374
CTRI/2024/09/074374尚未招募3 期

To find out the optimal treatment regimen for PCOS

PGIMER Postgraduate Institute of Medical education and Research1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2024年10月27日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
75
试验地点
1
主要终点
free androgen index

研究概览

简要总结

PCOS is the most common endocrinopathy in reproductive aged females. Most of the time standard treatment is Oral contraceptive pills which on long term use has multiple side effects. With this trial we want to find out optimal non OCP treatment regime of PCOS.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • age more than 18 years BMI less than 25 kg/m2 pcos diagnosed by rotterdam criteria ( phenotype 1, 2 and 3).

排除标准

  • age more than 40 years chronic illness acute infection malignancy type 2 diabetes.

结局指标

主要结局

free androgen index

时间窗: at baseline then at 9 months of treatment.

次要结局

  • menstrual cycle regulation,(improvement in hirsutism,)

研究者

发起方
PGIMER Postgraduate Institute of Medical education and Research
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Rama Walia

Post graduate institute of medical education and research.

研究点 (1)

Loading locations...

相似试验